Talkspace, Inc. (TALK)
USD 3.09
(-5.21%)
USD 3.09
(-5.21%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 150.04 Million USD | 25.49% |
| 2022 | 119.56 Million USD | 5.19% |
| 2021 | 113.67 Million USD | 49.19% |
| 2020 | 76.19 Million USD | 99.57% |
| 2019 | 38.17 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 46.05 Million USD | 1.41% |
| 2024 Q1 | 45.41 Million USD | 7.07% |
| 2024 Q3 | 138.84 Million USD | 2.91% |
| 2023 Q2 | 35.64 Million USD | 6.93% |
| 2023 Q1 | 33.33 Million USD | 10.23% |
| 2023 FY | 150.04 Million USD | 25.49% |
| 2023 Q4 | 42.41 Million USD | 9.76% |
| 2023 Q3 | 38.64 Million USD | 8.42% |
| 2022 Q2 | 29.84 Million USD | -1.01% |
| 2022 Q1 | 30.15 Million USD | 3.35% |
| 2022 FY | 119.56 Million USD | 5.19% |
| 2022 Q4 | 30.24 Million USD | 3.1% |
| 2022 Q3 | 29.33 Million USD | -1.72% |
| 2021 Q1 | 27.15 Million USD | 5.72% |
| 2021 FY | 113.67 Million USD | 49.19% |
| 2021 Q4 | 29.17 Million USD | 10.67% |
| 2021 Q3 | 26.35 Million USD | -14.92% |
| 2021 Q2 | 30.98 Million USD | 14.09% |
| 2020 Q3 | 21.5 Million USD | 20.29% |
| 2020 FY | 76.19 Million USD | 99.57% |
| 2020 Q4 | 25.68 Million USD | 19.45% |
| 2020 Q2 | 17.87 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 38.17 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 94.877% |
| Addus HomeCare Corporation | 1.05 Billion USD | 85.827% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | 23.414% |
| Amedisys, Inc. | 2.23 Billion USD | 93.291% |
| American Oncology Network, Inc. | 1.27 Billion USD | 88.27% |
| Astrana Health, Inc. | 1.38 Billion USD | 89.179% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 92.083% |
| IMAC Holdings, Inc. | 5.19 Million USD | -2787.146% |
| biote Corp. | 185.36 Million USD | 19.052% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -378.709% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 92.571% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | 75.965% |
| The Ensign Group, Inc. | 3.72 Billion USD | 95.977% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 91.023% |
| InnovAge Holding Corp. | 763.85 Million USD | 80.357% |
| Assure Holdings Corp. | 255 Thousand USD | -58741.176% |
| The Joint Corp. | 117.69 Million USD | -27.485% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 85.787% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -1348.518% |
| ModivCare Inc. | 2.75 Billion USD | 94.546% |
| NewGenIvf Group Limited | 5.13 Million USD | -2821.35% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -1093.484% |
| Option Care Health, Inc. | 4.3 Billion USD | 96.512% |
| P3 Health Partners Inc. | 1.26 Billion USD | 88.152% |
| P3 Health Partners Inc. | 1.26 Billion USD | 88.152% |
| The Pennant Group, Inc. | 544.89 Million USD | 72.463% |
| Surgery Partners, Inc. | 2.74 Billion USD | 94.53% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -2620.6% |
| Talkspace, Inc. | 150.04 Million USD | 0.0% |
| The Oncology Institute, Inc. | 324.23 Million USD | 53.724% |
| The Oncology Institute, Inc. | 324.23 Million USD | 53.724% |